Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema-Reference-Cited by-同舟云学术

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

Published:2018-07-26 Issue:4 Volume:379 Page:352-362
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Aygören-Pürsün Emel¹,Bygum Anette¹,Grivcheva-Panovska Vesna¹,Magerl Markus¹,Graff Jochen¹,Steiner Urs C.¹,Fain Olivier¹,Huissoon Aarnoud¹,Kinaciyan Tamar¹,Farkas Henriette¹,Lleonart Ramon¹,Longhurst Hilary J.¹,Rae William¹,Triggiani Massimo¹,Aberer Werner¹,Cancian Mauro¹,Zanichelli Andrea¹,Smith William B.¹,Baeza Maria L.¹,Du-Thanh Aurelie¹,Gompels Mark¹,Gonzalez-Quevedo Teresa¹,Greve Jens¹,Guilarte Mar¹,Katelaris Constance¹,Dobo Sylvia¹,Cornpropst Melanie¹,Clemons Desiree¹,Fang Lei¹,Collis Phil¹,Sheridan William¹,Maurer Marcus¹,Cicardi Marco¹

Affiliation:

1. From the Division of Hematology, Oncology, and Hemostaseology, Department of Children and Adolescents, Angioedema Center, University Hospital Frankfurt (E.A.-P.), and the Fraunhofer Institute for Molecular Biology and Applied Ecology, Translational Medicine and Pharmacology (J. Graff), Frankfurt, the Department of Dermatology and Allergy, Charité–Universitätsmedizin Berlin, Berlin (M. Magerl, M. Maurer), and the Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center,...

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1716995

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen transition and management of hereditary angioedema long-term prophylaxis in real life: a single-center case series;Orphanet Journal of Rare Diseases;2024-07-09

2. Reducing Brain Edema Using Berotralstat, an Inhibitor of Bradykinin, Repurposed as Treatment Adjunct in Glioblastoma;Neuroglia;2024-07-02

3. Hereditary angioedema: current therapeutic management and future approaches;Current Opinion in Allergy & Clinical Immunology;2024-05-13

4. Balancing efficacy and safety of complement inhibitors;Journal of Autoimmunity;2024-05

5. Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema;Journal of Comparative Effectiveness Research;2024-05